Immucell (ICCC) Return on Assets [ROA] (2011 - 2026)
Immucell (ICCC) posted Return on Assets [ROA] of -1.46% for Q2 2026, down 5.46 percentage points from 4.00% a year earlier.
Powered by 
Analysis
Immucell (ICCC) Return on Assets [ROA] (2011 - 2026) Analysis & Trends
For FY2025, Immucell's Return on Assets [ROA] came in at -2.37%, up 2.48 percentage points from FY2024.
- Annual Return on Assets [ROA] shows a five-year change of +0.21 percentage points (FY2020 to FY2025).
- In prior years, Immucell's Return on Assets [ROA] was -4.85% in FY2024 (+8.17 pp), -13.03% in FY2023 (-7.44 pp), -5.58% in FY2022 (-5.40 pp) and -0.18% in FY2021 (+2.40 pp).
- Quarterly Return on Assets [ROA] has run from a low of -14.23% in Q3 2023 to a high of 5.27% in Q3 2025 over five years.
- On a year-over-year basis, Return on Assets [ROA] increased in six of the last seven quarters, with an average year-over-year change of +6.67 percentage points.
- The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q3 2025, with a gain of 14.10 percentage points; the weakest was Q1 2023, with a drop of 16.70 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 10.60% |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 2.14% |
| 10 | Immucell | 94.82 Mn | 72.27 Mn | 2.44 Mn | -1.46% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.46% |
| Dec 31, 2025 | -2.36% |
| Sep 30, 2025 | 5.27% |
| Jun 30, 2025 | 4.00% |
| Mar 31, 2025 | -0.60% |
| Dec 31, 2024 | -4.82% |
| Sep 30, 2024 | -8.83% |
| Jun 30, 2024 | -9.54% |
| Mar 31, 2024 | -8.97% |
| Dec 31, 2023 | -13.07% |
| Sep 30, 2023 | -14.23% |
| Jun 30, 2023 | -13.81% |
| Mar 31, 2023 | -13.65% |
| Dec 31, 2022 | -5.84% |
| Sep 30, 2022 | -2.00% |
| Jun 30, 2022 | -0.26% |
| Mar 31, 2022 | 3.05% |
| Dec 31, 2021 | -0.18% |
| Sep 30, 2021 | 0.08% |
| Jun 30, 2021 | -1.04% |
API Access
Immucell Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ICCC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "ICCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ICCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();